Genetic changes over the last six million years have transformed the structure and function of the human brain. However, identifying the key genetic changes that transform developmental process has been challenging because developmental tissue is largely inaccessible to comparative and functional studies. This project will establish a systematic quantitative genetic approach for discovering the human-specific genomic changes that underlie unique features or vulnerabilities of the developing human brain. Our project leverages human and great ape pluripotent stem cell and cerebral organoid models that we have established to perform comparative analysis of gene activity and cell behavior during hominid cortical development. In addition, by incorporating advances in genome engineering screens and novel chromosome engineering strategies, this project will perform large-scale functional analysis of human-specific variants in the context of key processes of cortical development. Finally, this project involves the development of novel and generalizable tools for both the derivation of specific cell types from pluripotent stem cells across many individuals and species and for high-throughput analysis of cellular phenotypes. Ultimately, our vision of success will be a platform that enables a quantitative understanding of the extent to which individual human-specific mutations explain variation in specialized aspects of human brain development.

Public Health Relevance

This project will support our understanding of neurodevelopmental disorders and provide novel stem cell biology tools with general applications in regenerative medicine. Because many genes and cell types implicated in autism spectrum disorder and other neuropsychiatric disorders have changed in recent human evolution, it is crucial to delineate how human brain development differs from that of model organisms. In addition, our approach will allow us to study the function of recent genetic changes shared by all humans, including at loci prone to large structural rearrangements that are major contributors to neuropsychiatric disorders

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
NIH Director’s New Innovator Awards (DP2)
Project #
1DP2MH122400-01
Application #
9782266
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Panchision, David M
Project Start
2019-09-13
Project End
2024-05-31
Budget Start
2019-09-13
Budget End
2024-05-31
Support Year
1
Fiscal Year
2019
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Neurology
Type
Schools of Medicine
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94118